|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Rheumatic Diseases | |||||
| Rheumatoid Arthritis | |||||
| Systemic Lupus Erythematosus | |||||
| Scleroderma | |||||
| Dermatomyositis | |||||
| Myositis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arthritis | |||||
| Arthritis, Rheumatoid | |||||
| Lupus Erythematosus, Systemic | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Immune System Diseases | |||||
| Joint Diseases | |||||
| Muscular Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Polymyositis | |||||
| Skin Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Environmental Health Sciences (NIEHS) | |||||